In this special bonus session from the 2021 ALS Canada Research Forum, Dr. Martin Duennwald, from Western University, gave a talk entitled “Hsp90 and its co-chaperones modulate protein misfolding in ALS.”

You will also have the chance to see three minute “poster” presentations from:

  • Avyarthana Dey, University of Alberta
  • Lauren Forgrave, University of British Columbia
  • Ziyaan Harji, McGill University
  • Sunny Kumar, Université Laval
  • Pedram Parnianpour, University of Alberta
  • Anjali Patel, University of Ottawa

This webinar is available in English only.

Dr. David Taylor, VP of Research, hosted a webinar on June 15, 2021 exploring the current state of clinical trials globally and in Canada, where he also addressed some key questions around specific studies and clinical trials in general.

Clinical trials are a critical step in the development of ALS treatments – they are a series of studies to determine if a potential therapy is safe, tolerable and most importantly, effective at treating the disease.

This webinar is available in English only.

Hosted on October 21, 2020 this webinar featured panelists:

  • Dr. Kevin Eggan, Harvard Stem Cell Institute
  • Dr. Victor Rafuse, Dalhousie University
  • Dr. Rita Sattler, Barrow Neurological Institute
  • Dr. Clive Svendsen, Cedars-Sinai Regenerative Medicine Institute

This webinar is available in English only.

Hosted on November 18, 2020 this webinar featured panelists:

  • Dr. Sandrine Da Cruz, VIB-KU Leuven Center for Brain & Disease Research
  • Dr. Piera Pasinelli, Thomas Jefferson University
  • Dr. Ludo Van Den Bosch, VIB-KU Leuven Center for Brain & Disease Research
  • Dr. Christine Vande Velde, Universite de Montreal

This webinar is available in English only.

Hosted on September 16, 2020 this webinar featured panelists:

  • Dr. Thomas Cunningham, MRC Harwell Institute
  • Dr. Terry Heiman-Patterson, Temple University
  • Dr. Roger Sher, Stony Brook University
  • Dr. Fernando Vieira, ALS Therapy Development Institute

This webinar is available in English only.

Hosted on August 26, 2020 this webinar featured panelists:

  • Dr. Gary Armstrong, McGill University
  • Dr. Nicholas Cole, MND Association
  • Dr. Alex Parker, Universite de Montreal
  • Dr. Daniela Zarnescu, University of Arizona

This webinar is available in English only.

Dr. David Taylor, VP of Research, hosted a webinar on June 16, 2020 exploring the current state of clinical trials in Canada and worldwide. In this 1-hr archived session, you’ll learn about:

  • Phase 3 ALS clinical trials currently underway
  • Promising Phase 2 ALS clinical trials
  • Select early stage ALS clinical trials
  • Current and future processes of clinical trial development in Canada

This webinar is available in English only.

This webinar is about the impact of donations and the game-changing research that the ALS Ice Bucket Challenge made possible.

You’ll learn about:

  • Ongoing clinical trials and the promise they hold for finding future ALS treatments
  • New partnerships and collaborations on a provincial, national, and global level
  • ALS biomarker research aimed at helping to discover treatments faster and improve patient care

This webinar is offered in English only.

This webinar is part two of a two part series that focuses on clinical trials for ALS in Canada and across the world.

This is part two of a two part series where Dr. David Taylor, VP of Research at ALS Canada, continues to explore current ALS clinical trials, specific experimental treatments, how you can get involved in a clinical trial near you, and alternative ALS treatments.

This webinar is offered in English only.

This webinar is part one of a two part series that focuses on clinical trials for ALS in Canada and across the world.

Dr. David Taylor, VP of Research at ALS Canada, explores how clinical trials currently work, the importance of biomarkers, a new way of doing ALS clinical trials and the current state of experimental therapies in Canada and worldwide.

This webinar is offered in English only.

Question and answer period.

This is an archived presentation from ALS Canada’s 3rd annual Virtual Research Forum presented by Dr. David Taylor, Dr. Angela Genge, and Dr. Christine Vande Velde.

A new way of looking at experimental therapy for ALS.

This is an archived presentation from ALS Canada’s 3rd annual Virtual Research Forum, presented by Sahara Khademullah from l’Université Laval.

Using stem cells from adult blood to recreate individuals’ ALS in a dish.

This is an archived presentation from ALS Canada’s 3rd annual Virtual Research Forum, presented by Stefano Stifani and Mathilde Chaineau from McGill University.

Using zebrafish and cutting edge technology to create a better way of studying ALS in animals.

This is an archived presentation from ALS Canada’s 3rd annual Virtual Research Forum, presented by Dr. Gary Armstrong, Assistant Professor in the Department of Neurology and Neurosurgery at the Montreal Neurological Institute.

Using identical twins to understand environmental factors in ALS onset and progression.

This is an archived presentation from ALS Canada’s 3rd annual Virtual Research Forum, presented by Dr. Ekaterina Rogaeva from the University of Toronto.

A multidisciplinary initiative with a primary goal of promoting and prolonging safe driving for patients with ALS.

This is an archived presentation from ALS Canada’s 3rd annual Virtual Research Forum, presented by Kendra Berry from the Montreal Neurological Institute.

Using Brain Computer Interface Technology to turn thoughts into computer commands.

This is an archived presentation from ALS Canada’s 3rd annual Virtual Research Forum, presented by Nick Ramsey from the University Medical Center Utrecht.

A five year research project, searching for biomarkers of ALS and leaving a legacy resource to improve diagnosis and understanding of ALS for the future.

This is an archived presentation from ALS Canada’s 3rd annual Virtual Research Forum, presented by Professor Martin Turner from the University of Oxford.

A multi-national initiative, establishing a global resource of human data that will enable scientists worldwide to understand the genetic signature that leads someone to develop ALS.

This is an archived presentation from ALS Canada’s 3rd annual Virtual Research Forum, presented by Dr. Jan Veldink from UMC Utrecht.

Dr. François Gros-Louis provided an overview on the work his research lab is doing with ALS at l’Université Laval, using skin as an alternative to brain tissue to identify molecular biomarkers in ALS.

Please note that this webinar was presented in French only.